Ranibizumab With Prompt/Deferred Laser Or Alone Again Beats Laser
May 6, 2011
Submit Comments
Ophthalmology: Two large studies were published which confirmed what was demonstrated last year- that injections of Ranibizumab (Lucentis) with deferred (> 24 weeks) or prompt laser was superior to laser alone for diabetic retinopathy involving the central macula. Only 2-3 more injecions were required after the first year. One of the studies suggested that even the injections alone without any laser was better. We really ought to re-consider laser as the standard of care, and most likely, Avastin is just as good.
You might also enjoy...
- Do Triamcinolone Injections Improve Vision After Central Retinal Vein Occlusion?
- PrONTO Study Year 2: Evaluating a Variable-dosing Regimen with Intravitreal Lucentis (ranibizumab)
- Looks Like Avastin Is Best For Diabetic Retinopathy
- Is Macugen Better Than Panretinal Photocoagulation for Diabetic Retinopathy?
- Is Bevacizumab Better Than Photodynamic Therapy for Myopic Subretinal Neovascularization?
Comments
Jump down to form below to submit your own comments
